HLA matching in unrelated donor bone marrow transplantation

Current Opinion in Hematology

Volumn 3, Issue 6, 1996, Pages 416-422

  Charron, Dominique J ^a,b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

BONE MARROW TRANSPLANTATION; DONOR; GENE LOCUS; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HLA MATCHING; HLA TYPING; HUMAN; IMMUNE RESPONSE; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0029963728     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603060-00004     Document Type: Review

References (51)

1. Oudshoorn M, van Leeuwen A, Zanden HGM, van Rood JJ: Bone marrow donors worldwide : a successful exercise in international cooperation. Bone Marrow Transplant 1994, 14:3-8.
2. Charron D: HLA typing procedures and strategies in haematopoietic transplantation. Meet the Expert Sessions of the Second European Hematology Association. Oxford: Blackwell Science Ltd; 1996:63-66.
3. Kernan NA, O'Reilly RJ, Dupont B, Yang SY: Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990, 323:1818-1822.
4. Bodmer JG, Marsh GE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, et al.: Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995, 46:1-18. The nomenclature for factors of the HLA system is the world reference for naming the alleles. Based principally on DNA sequences, it allows comparison for data. Regular updates are published and are also available on the world wide web.
5. Charron D, ed: HLA Genetic Diversity : Functional and Medical Implications. Sèvres, France: EDK; in press.
6. Abstracts from the 12th International Histocompatibility Conference. Hum Immunol 1996, 47:1-2.
7. Cereb N, Maye P, Lee S, Kong Y, Yang SY: Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B and -C alleles. Tissue Antigens 1995, 45:1-11. This report describes locus-specific DNA sequences present in the first and third introns of the HLA-A, -B, and -C genes, thereby allowing locus-specific amplification. These data represent an important contribution for the development of HLA-A, -B, and -C molecular typing.
8. Browning MJ, Krausa P, Bodmer JG: Low resolution HLA-A locus typing by multiplex ARMS/PCR. Hum Immunol 1994, 39:143.
9. Sadler AM, Petronzelli F, Krausa P: Low-resolution DNA typing for HLA-B using sequence specific primers in allele- or group-specific ARMS/PCR. Tissue Antigens 1994, 44:148-154.
10. Bunce M, Welsh KI: Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP) : identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994, 43:6-17.
11. Gao X, Jakosen IB, Serjeantson SW: Characterization of the HLA-A polymorphism by locus-specific polymerase chain reaction amplification and ollgonucleotide hybridization. Hum Immunol 1994, 41:267-279.
12. Tatari Z, Fortier C, Bobrynina V, Loiseau P, Raffoux C, Charron D: HLA-Cw allele analysis by PCR-restriction fragment length polymorphism: study of known and additional alleles. Proc Natl Acad Sci U S A 1995, 92:8803-8807. Because of the imprecision of HLA-Cw serology, the biologic role of HLA-Cw in transplantation has been overlooked. A DNA-based HLA-Cw typing technique (PCR restriction fragment length polymorphism) was developed that allows the typing of over 22 different HLA-Cw alleles and identifies a series of new HLA-Cw alleles. The molecular identification of previously unrecognized HLA-Cw alleles and new HLA-Cw alleles (undetected by serology) has led to a reevaluation of the impact of Cw matching in transplantation.
13. Fernandez-Vina M, Lazaro AM, Sun Y, Miller S, Forero L, Stastny P: Population diversity of B-locus alleles observed by high-resolution DNA typing. Tissue Antigens 1995, 45:153-168.
14. Fleischhauer K, Zino E, Bordignon C, Benazzi E: Complete generic and extensive fine-specific typing of the HLA-B locus by the PCR-SSOP method. Tissue Antigens 1995, 46:281-292.
15. Rufer N, Breur-Vriesendorp B, Tiercy JM, Gauchat-Feiss D, Shi X, Slavcev A, Lardy N, Chapuis B, Gratwohl A, Speiser D, Jeannet M, Roosnek E: HLA-B35 subtype mismatches in ABDR serologically matched unrelated donor-recipient pairs. Hum Immunol 1994, 41:96-101.
16. Rufer N, Breur-Vriesendorp S, Tiercy JM, Slavcev AS, Lardy NM, Francis P, Kressig R, Speiser DE, Helg C, Chapuis B, Gratwohl A, Jeannet M, Roosnek E: High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs. Hum Immunol 1993, 38:235-239.
17. Santamaria P, Lindstrom AL, Boyce-Jacino MT, Myster SH, Barbosa JJ, Faras AJ, Rich SS: HLA class I sequence-based typing. Hum Immunol 1993, 37:39-50.
18. Rozemuller EH, Chadwick B, Charron D, Baxter-Lowe LA, Eliaou JF, Johnston-Dow L, Tilanus MGJ: Sequenase sequence profiles used for HLA-DPB1 sequencing based typing. Tissue Antigens 1995, 47:72-79.
19. Rozemuller EH, Eliaou JF, Baxter-Lowe LA, Charron D, Kronick M, Tilanus MGJ: An evaluation of a multicenter study on HLA-DPB1 typing using solid phase taq-cycle sequencing chemistry. Tissue Antigens 1995, 46:96-103.
20. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW, Appelbaum FR, Buckner CD, Matthews D, Storb R, Sullivan KM, Hansen JA: Unrelated donor marrow transplantation in children. Blood 1995, 86:3247-3256.
21. Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ, Mickelson EM, Choo SY, Petersdorf EW, Pepe MS, et al.: Marrow transplantation from unrelated donors for treatment of hematopoietic malignancies : effect of mismatching for one HLA locus. Blood 1993, 81:249-253.
22. Ringdén, Remberger M, Persson U, Ljungman P, Aldener A, Andström E, Aschan J, Bolme, Dahllöf G, Dalianis T, et al.: Similar incidence of graft-versus-host disease using HLA-A, -B and DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995, 15:619-625. Comparison between two cohorts of bone marrow allograft recipients (39 matched unrelated donors vs 39 HLA-identical sibling donors) reveals no significant difference in terms of incidence of grade I acute GVHD (63% vs 57%), actuarial probability of grade II-IV GVHD (15% vs 11%), chronic GVHD (29% vs 22%), or 2-year survival (59% vs 78%).
23. Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG, Hansen JA: The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995, 86:1606-1613. Retrospective study of 364 AB DR serologically matched bone marrow transplants from unrelated donors that concludes that DRB1 allelic matching based on molecular typing would decrease the relative risk of GVHD and transplant-related mortality and would increase the overall survival.
24. Mickelson EM, Guthrie LA, Etzioni R, Anasetti C, Martin PJ, Hansen JA: Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors. Tissue Antigens 1994, 44:83-92.
25. Al-Daccak R, Loiseau P, Rabian C, Devergie A, Bourdeau H, Raffoux C, Gluckman E, Colombani J: HLA-DR, DQ and /or DP genotypic mismatches between recipient-donor pairs in unrelated bone marrow transplantation and transplant clinical outcome. Transplantation 1990, 50:960-964.
26. Petersdorf EW, Smith AG, Mickelson EM, Longton GM, Anasetti C, Choo SY, Martin PJ, Hansen JA: The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993, 81:1923-1932.
27. Cesbron A, Moreau P, Milpied N, Harousseau JL, Muller JY, Bignon JD: Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction. Hum Immunol 1992, 33:202-207.
28. Rufer N, Tiercy JM, Breur-Vriesendorp B, Gauchat-Feiss D, Shi X, Slavcev A, Lardy N, Speiser D, Gratwohl A, Chapuis B, Jeannet M, Roosnek E: Histoincompatibilities in ABDR-matched unrelated donor recipient combinations. Bone Marrow Transplant 1995, 16:641-646.
29. Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM: Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 1995, 86:3590-3597.
30. Davies SM, Shu XO, Blazar BR, Filipavich AH, Kersey JH, Krivit W, McCullough J, Miller WJ, Ramsay NKC, Segall M, Wagner JE, Weisdorf DJ, McGlave PB: Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995, 86:1632-1642.
31. Speiser DE, Tiercy JM, Rufer N, Grundschober C, Gratwohl A, Chapuis B, Helg C, Löliger CC, Siren MK, Roosnek E, Jeannet M: High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996, 87:4455-4462.
32. Mantovani V, Martinelli G, Bragliani M, Buzzi M, Selva P, Collina E, Farabegoli P, Rosti GA, Bandini G, Tura S, Barboni F: Molecular analysis of HLA genes for the selection of unrelated bone marrow donor. Bone Marrow Transplant 1995, 16:329-335.
33. Petersdorf EW, Stanley JF, Martin PJ, Hansen JA: Molecular diversity of the HLA-C locus in unrelated marrow transplantation. Tissue Antigens 1994, 44:93-99.
34. Esperou H, Tatari Z, Fortier C, Bensa JC, Traineau R, Souillet G, Moreau PH, Gluckman E, Charron D, Raffoux C: Influence of donor/recipients HLA-C disparity in 70 unrelated bone marrow transplantation. Blood 1995, 86:291.
35. Tatari Z, Esperou H, Chastang C, Fortier C, Tamouza R, Gluckman E, Charron D, Raffoux C: Influence of donor-recipient HLA-C disparity on outcome of unrelated bone marrow transplants. In HLA Genetic Diversity: Functional and Medical Implications. Edited by Charron D. Sèvres, France: EDK; in press.
36. Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp Hematol 1995, 23:1667-1675.
37. Colonna M, Samaridis J: Cloning of Ig superfamily members associated with HLA-C and HLA-B recognition by human NK cells. Science 1995, 268:405-408.
38. Albi N, Ruggeri L, Aversa F, Merigiola C, Tosti A, Tognellini R, Grossi CE, Martelli MF, Velardi A: Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation. Blood 1996, 87:3993-4000.
39. Tay GK, Witt CS, Christiansen FT, Charron D, Baker D, Herrmann R, Smith LK, Diepeveen D, Mallal S, McCluskey J, et al.: Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation. Bone Marrow Transplant 1995, 15:381-385. A DNA-based HLA haplotype matching technique using non-HLA DNA polymorphisms in the MHC as markers of blocks of ancestral haplotypes identifies shared evolutionary related HLA haplotypes. Such haplotype matching appears beneficial in terms of lower incidence of GVHD and longer survival in a series of 45 BMT cases.
40. Schipper RF, D'Amaro J, Oudshoorn M: The probability of finding a suitable related donor for bone marrow transplantation in extended families. Stood 1996, 87:800-804. Based on the assumption that family donors are better donors because they share complete haplotypes with the recipient, this work suggests that a suitable donor should be sought among cousins and blood-related aunts and uncles (the extended family). This would reduce the search time. A computer program is proposed that calculates the probability of finding a donor in the extended family given the combination of haplotype frequencies and family composition.
41. Morishima Y, Kodera Y, Hirabayashi N, Tanimoto M, Matsuyama T, Horibe K, Ohta H, Mizuno S, Morishita Y, Yamauchi T, et al., and the Tokai Marrow Donor Bank: Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,Dr-compatible unrelated donors among Japanese. Bone Marrow Transplant 1995, 15:235-239.
42. Kovats S, Main EK, Librach C, et al.: A class I antigen HLA-G expressed in human trophoblast. Science 1990, 248:220-223.
43. Bahram S, Bresnahan M, Geraghty DE, Spies T: A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994, 91:6259-6263.
44. Blazar BR, Taylor P, Panoskaltsis-Mortari A, Barrett RA, Bluestone JA, Vallera DA: Lethal murine graft-versus-host disease induced by donor γ/δ expressing T cells with specificity for host non classical major histocompatibility complex class Ib antigens. Blood 1996, 87:827-837.
45. Bahram S, Spies T: Nucleotide sequence of a human MHC class I MICB cDNA. Immunogenetics 1996, 43:230-233.
46. Visser CJ, Charron D, Tamouza R, Tatari Z, Rozemuller EH, Tilanus MGJ: MHC class I chain-related gene-A (MICA) polymorphism. In HLA Genetic Diversity: Functional and Medical Implications. Edited by Charron D. Sèvres, France: EDK; in press.
47. Goulmy E, Schipper DR, Pool J, Blokland E, Falkenburg JHF, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, van Rood JJ: Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996, 334:281-285.
48. Behar EB, Charo NJ, Debra MD, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC: Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996, 286-291. The first report that a DNA polymorphism of the CD31 gene (coding for an adhesion molecule) that was assessed by direct DNA sequencing increases the risk of acute GVHD. The study was conducted retrospectively in 46 patients receiving bone marrow transplants from HLA-identical sibling donors.
49. Wang Wei, Meadows LR, den Haan JMM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE, Hunt DF, Goulmy E, Engelhard VH: Human H-Y: a male-specific histocomptability antigen derived from the SMCY protein. Science 1995, 269:1588-1590.
50. Sidney J, Grey HM, Kubo RT, Sette A: Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today 1996, 17:261.
51. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D: Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995, 86:3979-3986. Late infections appear more frequent after allogeneic transplantation from unrelated donors (98 cases, 84.7%) than from HLA-identical siblings (151 cases, 68.2%). This may reflect the positive impact of HLA allelic and haplotype matching in controling the immune response against infectious agents.